Ebola Virus Disease (EVD) stands out as a fatal epidemic disease that has garnered international attention due to its high mortality rates and potential for rapid spread. The Ebola virus, a member of the Filoviridae family, causes severe hemorrhagic fever in humans. Originating from bats and transmitted to humans through the handling of infected animals, EVD has led to devastating outbreaks in several African countries, with the 2014-2016 West African epidemic being particularly notable. EVD is characterized by a sudden onset of fever, weakness, muscle pain, and impaired kidney and liver function. As the disease progresses, it can result in internal and external bleeding, leading to a high fatality rate. The lack of specific antiviral treatments and the challenges in implementing effective control measures, such as contact tracing and isolation, contribute to the severity of EVD outbreaks. International collaborations, improved surveillance systems, and advancements in vaccine development have been critical in addressing EVD. The World Health Organization (WHO) and other organizations have played pivotal roles in coordinating responses and providing support to affected regions. Research continues to focus on understanding the virus's biology and improving preparedness strategies to mitigate the impact of future Ebola outbreaks.